{"id":44195,"date":"2021-02-18T14:33:33","date_gmt":"2021-02-18T14:33:33","guid":{"rendered":"https:\/\/conseil-concurrence.preprod.io\/reunion-de-la-commission-permanente-40\/"},"modified":"2026-02-06T16:44:32","modified_gmt":"2026-02-06T16:44:32","slug":"meeting-of-the-permanent-commission-3","status":"publish","type":"post","link":"https:\/\/conseil-concurrence.ma\/en\/meeting-of-the-permanent-commission-3\/","title":{"rendered":"Meeting of the Permanent Commission"},"content":{"rendered":"<p style=\"text-align: justify;\"><span style=\"font-size: 13pt;\">The Permanent Commission of the Competition Council held its meeting, via videoconference, on Thursday, February 18, 2021 at 9:00 a.m., under the chairmanship of Mr. Driss Guerraoui, President of the Council.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-size: 13pt;\">At the beginning of its work, the Permanent Commission approved the minutes of its meeting held on February 11, 2021.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-size: 13pt;\">During this meeting, and noting the absence of impacts on competition in the relevant national markets, the Permanent Commission made decisions to authorize the following four economic concentration operations:<\/span><\/p>\n<ul style=\"list-style-type: circle;\">\n<li style=\"list-style-type: none;\">\n<ul style=\"list-style-type: circle;\">\n<li style=\"list-style-type: none;\">\n<ul style=\"text-align: justify;\">\n<li style=\"list-style-type: none;\">\n<ul style=\"text-align: justify;\">\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"text-align: justify;\"><span style=\"font-size: 13pt;\">The joint control of the Tanger Tech Development Company (SATT) through the acquisition of 20% of the Tanger Med Special Agency (TMSA) and 35% of the capital and voting rights by Beijing Zhonglu Urban Development Company Ltd;<\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 13pt;\">The direct exclusive control of Cheplapharm Arzneimittel Gmbh through the acquisition of assets of Sanofi related to the production and marketing of Sectral and Corvasal medicines used in the treatment of heart diseases;<\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 13pt;\">The exclusive control through the acquisition of Zephyr German BidCo Gmbh of all the share capital and voting rights of FlenderGmbh;<\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 13pt;\">The direct exclusive control of the Akdital holding group through the acquisition of all the shares of the capital of Gimes da vinci sarlu, which operates the De vinci Clinic&#8221;.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>The Permanent Commission of the Competition Council held its meeting, via videoconference, on Thursday, February 18, 2021 at 9:00 a.m., under the chairmanship of Mr. Driss Guerraoui, President of the Council. At the beginning of its work, the Permanent Commission approved the minutes of its meeting held on February 11, 2021. During this meeting, and noting the absence of impacts on competition in the relevant national markets, the Permanent Commission made decisions to authorize the following four economic concentration operations: The joint control of the Tanger Tech Development Company (SATT) through the acquisition of 20% of the Tanger Med Special Agency (TMSA) and 35% of the capital and voting rights by Beijing Zhonglu Urban Development Company Ltd; The direct exclusive control of Cheplapharm Arzneimittel Gmbh through the acquisition of assets of Sanofi related to the production and marketing of Sectral and Corvasal medicines used in the treatment of heart diseases; The exclusive control through the acquisition of Zephyr German BidCo Gmbh of all the share capital and voting rights of FlenderGmbh; The direct exclusive control of the Akdital holding group through the acquisition of all the shares of the capital of Gimes da vinci sarlu, which operates the De vinci Clinic&#8221;.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[352],"tags":[383],"class_list":["post-44195","post","type-post","status-publish","format-standard","hentry","category-press-releases","tag-2023-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Meeting of the Permanent Commission - Conseil de la concurrence du Maroc<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/conseil-concurrence.ma\/en\/meeting-of-the-permanent-commission-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Meeting of the Permanent Commission - Conseil de la concurrence du Maroc\" \/>\n<meta property=\"og:description\" content=\"The Permanent Commission of the Competition Council held its meeting, via videoconference, on Thursday, February 18, 2021 at 9:00 a.m., under the chairmanship of Mr. Driss Guerraoui, President of the Council. At the beginning of its work, the Permanent Commission approved the minutes of its meeting held on February 11, 2021. During this meeting, and noting the absence of impacts on competition in the relevant national markets, the Permanent Commission made decisions to authorize the following four economic concentration operations: The joint control of the Tanger Tech Development Company (SATT) through the acquisition of 20% of the Tanger Med Special Agency (TMSA) and 35% of the capital and voting rights by Beijing Zhonglu Urban Development Company Ltd; The direct exclusive control of Cheplapharm Arzneimittel Gmbh through the acquisition of assets of Sanofi related to the production and marketing of Sectral and Corvasal medicines used in the treatment of heart diseases; The exclusive control through the acquisition of Zephyr German BidCo Gmbh of all the share capital and voting rights of FlenderGmbh; The direct exclusive control of the Akdital holding group through the acquisition of all the shares of the capital of Gimes da vinci sarlu, which operates the De vinci Clinic&#8221;.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/conseil-concurrence.ma\/en\/meeting-of-the-permanent-commission-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Conseil de la concurrence du Maroc\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-18T14:33:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-06T16:44:32+00:00\" \/>\n<meta name=\"author\" content=\"Youssef OTMANE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Youssef OTMANE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/meeting-of-the-permanent-commission-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/meeting-of-the-permanent-commission-3\\\/\"},\"author\":{\"name\":\"Youssef OTMANE\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#\\\/schema\\\/person\\\/24b4bd1e24ccf3057c8fcb57662a0b81\"},\"headline\":\"Meeting of the Permanent Commission\",\"datePublished\":\"2021-02-18T14:33:33+00:00\",\"dateModified\":\"2026-02-06T16:44:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/meeting-of-the-permanent-commission-3\\\/\"},\"wordCount\":200,\"keywords\":[\"2023\"],\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/meeting-of-the-permanent-commission-3\\\/\",\"url\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/meeting-of-the-permanent-commission-3\\\/\",\"name\":\"Meeting of the Permanent Commission - Conseil de la concurrence du Maroc\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#website\"},\"datePublished\":\"2021-02-18T14:33:33+00:00\",\"dateModified\":\"2026-02-06T16:44:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#\\\/schema\\\/person\\\/24b4bd1e24ccf3057c8fcb57662a0b81\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/meeting-of-the-permanent-commission-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/meeting-of-the-permanent-commission-3\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/meeting-of-the-permanent-commission-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Meeting of the Permanent Commission\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/\",\"name\":\"Conseil de la concurrence du Maroc\",\"description\":\"Conseil de la concurrence\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#\\\/schema\\\/person\\\/24b4bd1e24ccf3057c8fcb57662a0b81\",\"name\":\"Youssef OTMANE\",\"url\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Meeting of the Permanent Commission - Conseil de la concurrence du Maroc","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/conseil-concurrence.ma\/en\/meeting-of-the-permanent-commission-3\/","og_locale":"en_US","og_type":"article","og_title":"Meeting of the Permanent Commission - Conseil de la concurrence du Maroc","og_description":"The Permanent Commission of the Competition Council held its meeting, via videoconference, on Thursday, February 18, 2021 at 9:00 a.m., under the chairmanship of Mr. Driss Guerraoui, President of the Council. At the beginning of its work, the Permanent Commission approved the minutes of its meeting held on February 11, 2021. During this meeting, and noting the absence of impacts on competition in the relevant national markets, the Permanent Commission made decisions to authorize the following four economic concentration operations: The joint control of the Tanger Tech Development Company (SATT) through the acquisition of 20% of the Tanger Med Special Agency (TMSA) and 35% of the capital and voting rights by Beijing Zhonglu Urban Development Company Ltd; The direct exclusive control of Cheplapharm Arzneimittel Gmbh through the acquisition of assets of Sanofi related to the production and marketing of Sectral and Corvasal medicines used in the treatment of heart diseases; The exclusive control through the acquisition of Zephyr German BidCo Gmbh of all the share capital and voting rights of FlenderGmbh; The direct exclusive control of the Akdital holding group through the acquisition of all the shares of the capital of Gimes da vinci sarlu, which operates the De vinci Clinic&#8221;.","og_url":"https:\/\/conseil-concurrence.ma\/en\/meeting-of-the-permanent-commission-3\/","og_site_name":"Conseil de la concurrence du Maroc","article_published_time":"2021-02-18T14:33:33+00:00","article_modified_time":"2026-02-06T16:44:32+00:00","author":"Youssef OTMANE","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Youssef OTMANE","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/conseil-concurrence.ma\/en\/meeting-of-the-permanent-commission-3\/#article","isPartOf":{"@id":"https:\/\/conseil-concurrence.ma\/en\/meeting-of-the-permanent-commission-3\/"},"author":{"name":"Youssef OTMANE","@id":"https:\/\/conseil-concurrence.ma\/en\/#\/schema\/person\/24b4bd1e24ccf3057c8fcb57662a0b81"},"headline":"Meeting of the Permanent Commission","datePublished":"2021-02-18T14:33:33+00:00","dateModified":"2026-02-06T16:44:32+00:00","mainEntityOfPage":{"@id":"https:\/\/conseil-concurrence.ma\/en\/meeting-of-the-permanent-commission-3\/"},"wordCount":200,"keywords":["2023"],"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/conseil-concurrence.ma\/en\/meeting-of-the-permanent-commission-3\/","url":"https:\/\/conseil-concurrence.ma\/en\/meeting-of-the-permanent-commission-3\/","name":"Meeting of the Permanent Commission - Conseil de la concurrence du Maroc","isPartOf":{"@id":"https:\/\/conseil-concurrence.ma\/en\/#website"},"datePublished":"2021-02-18T14:33:33+00:00","dateModified":"2026-02-06T16:44:32+00:00","author":{"@id":"https:\/\/conseil-concurrence.ma\/en\/#\/schema\/person\/24b4bd1e24ccf3057c8fcb57662a0b81"},"breadcrumb":{"@id":"https:\/\/conseil-concurrence.ma\/en\/meeting-of-the-permanent-commission-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/conseil-concurrence.ma\/en\/meeting-of-the-permanent-commission-3\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/conseil-concurrence.ma\/en\/meeting-of-the-permanent-commission-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/conseil-concurrence.ma\/en\/"},{"@type":"ListItem","position":2,"name":"Meeting of the Permanent Commission"}]},{"@type":"WebSite","@id":"https:\/\/conseil-concurrence.ma\/en\/#website","url":"https:\/\/conseil-concurrence.ma\/en\/","name":"Conseil de la concurrence du Maroc","description":"Conseil de la concurrence","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/conseil-concurrence.ma\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/conseil-concurrence.ma\/en\/#\/schema\/person\/24b4bd1e24ccf3057c8fcb57662a0b81","name":"Youssef OTMANE","url":"https:\/\/conseil-concurrence.ma\/en\/"}]}},"_links":{"self":[{"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/posts\/44195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/comments?post=44195"}],"version-history":[{"count":1,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/posts\/44195\/revisions"}],"predecessor-version":[{"id":45688,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/posts\/44195\/revisions\/45688"}],"wp:attachment":[{"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/media?parent=44195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/categories?post=44195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/tags?post=44195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}